EMS: Brazil's Leading Pharmaceutical Powerhouse
In the landscape of South American healthcare, EMS stands as the largest domestic pharmaceutical company in Brazil. Established in 1950, the company has evolved from a local operation into a global player, providing a vast array of medications to millions of patients. With a strategic focus on accessibility and diversity in drug production, EMS has cemented its position as a cornerstone of the Brazilian medical industry.
Key Facts
- Founded: 1950
- Headquarters: Hortolândia, Brazil
- CEO: Waldir Eschberger
- Revenue: US$ 1.3 billion (2016)
- Workforce: 4,500 employees
- Global Reach: Presence in over 30 countries
Operational Infrastructure and Global Reach
EMS maintains a robust manufacturing network to support its high production volume. The company operates six industrial plants strategically located across Brazil and internationally. These facilities are situated in São Bernardo do Campo, Hortolândia, and Jaguariúna within the state of São Paulo, as well as in Manaus and Brasília. Expanding its footprint beyond South America, EMS also operates a plant in Belgrade, Serbia.
[ไม่มีภาพประกอบ]
The company's growth is further bolstered by its subsidiaries, including Galenika a.d. and Brace Pharma. Through a combination of joint ventures and strategic partnerships, EMS has successfully extended its market presence to more than 30 countries worldwide.
Diverse Business Divisions
To effectively manage its wide product portfolio, EMS operates through five specialized divisions, each targeting a specific segment of the healthcare market:
- EMS Similars: Focuses on similares, a specific class of pharmaceuticals unique to the Brazilian market that are neither original brands nor generics.
- EMS Generics: Dedicated to the production and marketing of generic drugs.
- EMS Sigma Pharma: Specializes in the marketing of branded medicines.
- EMS Hospital: Provides essential drugs and medical supplies directly to hospital environments.
- EMS Consumer: Manages the distribution of OTC (Over-the-Counter) drugs, which are medications sold directly to consumers without a prescription.
Market Position and Competition
As the dominant domestic player in Brazil, EMS faces competition from other major pharmaceutical entities. Its primary rivals in the Brazilian market include Hypera Pharma, Eurofarma, Aché, and Cristália.
| Category | Details |
|---|---|
| Industry | Pharmaceuticals |
| Ownership | Private |
| Key Products | Drugs and Generic Drugs |
| Main Competitors | Hypera Pharma, Eurofarma, Aché, Cristália |
| Website | www.ems.com.br |
Frequently Asked Questions
Where is EMS headquartered?
EMS is headquartered in Hortolândia, Brazil.
What are "similares" in the Brazilian pharmaceutical market?
Similares are a specific class of pharmaceuticals peculiar to Brazil; they are distinct from both original brand-name drugs and generic medications.
How many employees does EMS have?
The company employs approximately 4,500 people.
Does EMS operate outside of Brazil?
Yes, EMS has a presence in over 30 countries through strategic partnerships and joint ventures, and it operates an industrial plant in Belgrade, Serbia.
Who is the current CEO of EMS?
The company is led by CEO Waldir Eschberger.